摘要 |
A method for the treatment of a host, and in particular, a human, infected with HBV or EBV is provided that includes administering an HBV- or EBV- treatment amount of an L-nucleoside of formula(I) wherein R is a purine or pyrimidine base. In one preferred embodiment, the active compound is 2'-fluoro-5-methyl- beta -L-arabinofuranosyluridine (also referred to as L-FMAU). This compound is a potent antiviral agent against HBV and EBV and exhibits low cytotoxicity. Other specific examples of active compounds include N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-ethyluracil, N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodocytosine), and N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodouracil.
|
申请人 |
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.;YALE UNIVERSITY;CHU, CHUNG, K.;CHENG, YUNG-CHI;PAI, BALAKRISHNA, S.;YAO, GANG-QING |
发明人 |
CHU, CHUNG, K.;CHENG, YUNG-CHI;PAI, BALAKRISHNA, S.;YAO, GANG-QING |